Evidence map›Paper›PMID 42875050›Full record

ArticleJournal for immunotherapy of cancer2026

Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.

Yunbo Yu, Yuheng Liu, Xin Zhang, Wenyue Yang, Sencong Hou, Wenqian Yu, Feifei Zhang, Bo Yu, Zhihuang Hu, Zhenhua Wu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal for immunotherapy of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yunbo YuDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yuheng LiuDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xin ZhangDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wenyue YangDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Sencong HouDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wenqian YuFudan University Shanghai Cancer Center, Shanghai, China.
Feifei ZhangFudan University Shanghai Cancer Center, Shanghai, China.
Bo YuDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhihuang HuDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID http://orcid.org/0000-0002-6547-3832
Zhenhua WuDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shenglin HuangDepartment of Oncology, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-1279-0794
Jialei WangDepartment of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China luwangjialei@126.com.ORCID http://orcid.org/0000-0001-9977-2219

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkerImmunotherapyNon-Small Cell Lung Cancer

Identifiers

PMID42875050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.